All In MedTech

Device Trial Radar · NCT06078878

Clinical Feasibility Evaluation of the Gentuity HF-OCT Imaging System With Vis-M Micro-Imaging Catheter

Last checked: Nov 20, 2026Latest source record: Mar 30, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

30

Planned (sponsor's estimate)

Start

Feb 13, 2023

Primary completion

Sep 2026

Study completion Dec 2026

Sponsor

Lead sponsor
Gentuity, LLCNot on our public-company list
Sponsor type
Industry
First posted
Oct 12, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Sequential
Masking
None
Primary purpose
Other
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a prospective, single arm, unblinded, and open-label study. The study is designed to evaluate the use of the Gentuity Neurovascular Imaging System in patients undergoing elective neurointerventional diagnostic procedures.

Conditions

  • Anatomy

Interventions

  • HF-OCT Imaging System with Vis-M Micro-Imaging CatheterDevice

    Subjects undergo HF-OCT imaging of the desired intravascular segement

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Device SafetyTime frame: 7 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Clínica La Sagrada Familia

    Buenos Aires, Argentina · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.